MeenakshiSinghMD

PubMed

• 8 citations
  The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group...
  Ian S. Hagemann, Wei Deng, Richard J. Zaino, Matthew A. Powell, Camille C. Gunderson, Casey Cosgrove, Cara Mathews, Michael L. Pearl, Steven E. Waggoner, Rahel G Ghebr...> ;Gynecologic Oncology. 2021 Mar 1
• 10 citations
  Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.
  Abigail Winder, Kruti P. Maniar, Jian-Jun Wei, Dachao Liu, Denise M. Scholtens, John R. Lurain, Julian C. Schink, Barbara M. Buttin, Virginia L. Filiaci, Heather A. La...> ;Cancer. 2017 Apr 1
• 40 citations
  Endometrial Carcinoma: Role of Current and Emerging Biomarkers in Resolving Persistent Clinical Dilemmas.
  Tatiana Buhtoiarova, Carol A Brenner, Meenakshi Singh> ;American Journal of Clinical Pathology. 2016 Jan 1
• 27 citations
  Her2 and Ki67 Biomarkers Predict Recurrence of Ductal Carcinoma in Situ.
  James E. Davis, Barbara Nemesure, Saira Mehmood, Vipul Nayi, Stephanie Burke, Sabrina Brzostek, Meenakshi Singh> ;Applied Immunohistochemistry & Molecular Morphology. 2016 Jan 1
• 115 citations
  Triple-negative breast carcinoma: current and emerging concepts.
  Robert Schmadeka, Bryan E. Harmon, Meenakshi Singh> ;American Journal of Clinical Pathology. 2014 Apr 1
• 43 citations
  A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: A Gynecologic Oncology Group study ☆
  Kimberly K. Leslie, Michael W. Sill, Edgar G. Fischer, Kathleen M. Darcy, Robert S. Mannel, Krishnansu S. Tewari, Parviz Hanjani, Jason A. Wilken, Andre T. Baron, Andr...> ;Gynecologic Oncology. 2013 Jun 1
• 39 citations
  Use of telecytology for the immediate assessment of CT guided and endoscopic FNA cytology: diagnostic accuracy, advantages, and pitfalls.
  Alan Heimann, Gary Maini, Sonya Hwang, Kenneth R. Shroyer, Meenakshi Singh> ;Diagnostic Cytopathology. 2012 Jul 1
• 36 citations
  Immunocytochemical colocalization of P16(INK4a) and Ki-67 predicts CIN2/3 and AIS/adenocarcinoma.
  Meenakshi Singh, Daniel C. Mockler, Ali Akalin, Stephanie Burke, A. Laurie Shroyer, Kenneth R. Shroyer> ;Cancer Cytopathology. 2012 Feb 25
• 15 citations
  Dual stain immunohistochemical localization of p16INK4A and ki-67: a synergistic approach to identify clinically significant cervical mucosal lesions.
  Panduka Samarawardana, Meenakshi Singh, Kenneth R. Shroyer> ;Applied Immunohistochemistry & Molecular Morphology. 2011 Dec 1
• 27 citations
  Cadherins, catenins and cell cycle regulators: impact on survival in a Gynecologic Oncology Group phase II endometrial cancer trial.
  Meenakshi Singh, Kathleen M. Darcy, William E. Brady, Rashna Clubwala, Zachary Weber, Jon V. Rittenbach, Ali Akalin, Charles W. Whitney, Richard J. Zaino, Nilsa C. Ram...> ;Gynecologic Oncology. 2011 Nov 1
• 21 citations
  Voice recognition technology implementation in surgical pathology: advantages and limitations.
  Meenakshi Singh, Timothy Pal> ;Archives of Pathology & Laboratory Medicine. 2011 Oct 27
• 42 citations
  Ethnic Disparities in Breast Tumor Phenotypic Subtypes in Hispanic and Non-Hispanic White Women
  Lisa M. Hines, Betsy Risendal, Tim Byers, Sarah Mengshol, Jan T. Lowery, Meenakshi Singh> ;Journal of Women's Health. 2011 Oct 7
• 32 citations
  Differential expression of transferrin receptor (TfR) in a spectrum of normal to malignant breast tissues: implications for in situ and invasive carcinoma.
  Meenakshi Singh, Kimberly C. Mugler, Dulan W. Hailoo, Stephanie Burke, Barbara Nemesure, Kathleen C. Torkko, Kenneth R. Shroyer> ;Applied Immunohistochemistry & Molecular Morphology. 2011 Oct 1
• 2 citations
  Lobular endocervical glandular hyperplasia with extensive mucinous differentiation of endometrium and endometrial mucinous adenocarcinoma in situ: a case report and re...
  Martin M. Dinges, Dana Jaggessarsingh, Thomas Petersen, Kian Behbakht, Meenakshi Singh> ;Gynecologic Oncology. 2011 Sep 1
• 3 citations
  Pediatric solid malignant neoplasms: a comparative analysis
  Bryan E. Harmon, Kenneth Friedman, Barbara Nemesure, Meenakshi Singh> ;Indian Journal of Pathology & Microbiology. 2011 Jul 1
• 8 citations
  Differential expression of prognostic biomarkers between interval and screen-detected breast cancers: does age or family history matter?
  Jan T. Lowery, Tim Byers, John Kittelson, John E. Hokanson, Judy Mouchawar, John M. Lewin, Daniel T. Merrick, Lisa M. Hines, Meenakshi Singh> ;Breast Cancer Research and Treatment. 2011 Mar 24
• 18 citations
  Complementary approaches to assessing risk factors for interval breast cancer
  Jan T. Lowery, Tim Byers, John E. Hokanson, John Kittelson, John M. Lewin, Betsy Risendal, Meenakshi Singh, Judy Mouchawar> ;Cancer Causes & Control. 2011 Jan 1
• 38 citations
  p16INK4a is superior to high-risk human papillomavirus testing in cervical cytology for the prediction of underlying high-grade dysplasia
  Panduka Samarawardana, Donna L. Dehn, Meenakshi Singh, Douglas Franquemont, Chesney Thompson, Loretta Gaido, Kathleen C. Torkko, Petra Homer, Stephanie Burke, Matthew ...> ;Cancer Cytopathology. 2010 Jun 25
• 11 citations
  Discovery and verification of protein differences between Er positive/Her2/neu negative breast tumor tissue and matched adjacent normal breast tissue
  Lindsay-Rae B. Weitzel, Tim Byers, Jenna Allen, Christina Finlayson, Steve M. Helmke, John E. Hokanson, Stephen W. Hunsucker, James Murphy, Keri Newell, Kelly Queensla...> ;Breast Cancer Research and Treatment. 2010 Jan 20
• 10 citations
  Desmoid tumors of the right rectus abdominus muscle in postpartum women.
  Carmen Carneiro, Cheryl Hurtubis, Meenakshi Singh, William A. Robinson> ;Archives of Gynecology and Obstetrics. 2009 Jun 1
• A perimenopausal woman with a small, ER/HER2-positive, node-negative breast cancer.
  Brooks G, Borges, Meenakshi Singh, Rachel Rabinovitch, Christina Finlayson, Anthony D. Elias> ;Oncology. 2008 Oct 1
• 111 citations
  ZEB1 expression in type I vs type II endometrial cancers : a marker of aggressive disease
  Meenakshi Singh, Nicole S. Spoelstra, Annie Jean, Erin N. Howe, Kathleen C. Torkko, Hilda R Clark, Douglas S. Darling, Kenneth R. Shroyer, Kathryn B. Horwitz, Russell ...> ;Modern Pathology. 2008 May 16
• 77 citations
  Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice.
  Komal Raina, Subapriya Rajamanickam, Gagan Deep, Meenakshi Singh, Rajesh Agarwal, Chapla Agarwal> ;Molecular Cancer Therapeutics. 2008 May 1
• 26 citations
  Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: tamoxifen agonist effects dominate in the presence of an aromatase i...
  Djuana M. E. Harvell, Jennifer K. Richer, Meenakshi Singh, Nicole S. Spoelstra, Christina Finlayson, Virginia F. Borges, Anthony D. Elias, Kathryn B. Horwitz> ;Breast Cancer Research and Treatment. 2008 Mar 13
• 46 citations
  Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance.
  Djuana M. E. Harvell, Nicole S. Spoelstra, Meenakshi Singh, James L. McManaman, Christina Finlayson, Tzu L. Phang, Susan Trapp, Lawrence Hunter, Wendy W. Dye, Virginia...> ;Breast Cancer Research and Treatment. 2008 Mar 9
• Join now to see all